Concepedia

Author

Helen Eagleton

John Radcliffe Hospital

Also Known As

H Eagleton, H. Eagleton, Helen Eagleton, Helen J Eagleton, Helen Jane Eagleton

19

Publications

389

Citations

10

H-Index

30

Concepts

All Affiliations

John Radcliffe HospitalSt Bartholomew's HospitalKing's College LondonBlood Cancer UKStoke Mandeville Hospital
HE

About

Helen Eagleton is an author at John Radcliffe Hospital specializing in hematology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

134

2

Cell Biology

2

2

108

3

Immunology

2

2

66

4

Health Sciences

1

1

55

5

Cellular Therapies

1

1

13

Helen Eagleton

×

9

Publications

346

Citations

9

H-Index

YearCitations

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology

Andrea Pellagatti, Noor Esoof, Fiona Watkins,

British Journal of Haematology

2004

81

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

Louise J. Campbell, Carrie Fidler, Helen Eagleton,

Leukemia

2006

55

Gene expression profiling in polycythemia vera using cDNA microarray technology.

Andrea Pellagatti, David Vetrie, Cordelia F. Langford,

PubMed

2003

53

Terminal complement inhibition dampens the inflammation during COVID‐19

Austin Kulasekararaj, Joanna Large, Kristina Posadas,

British Journal of Haematology

2020

51

Neutropenia and anaemia associated with T‐cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity

Alexander Sternberg, Helen Eagleton, Nithiya Pillai,

British Journal of Haematology

2003

35

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman,

Journal of Clinical Oncology

2024

31

Low expression of the putative tumour suppressor gene <i>gravin</i> in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia

Jacqueline Boultwood, Andrea Pellagatti, Fiona Watkins,

British Journal of Haematology

2004

14

Favourable outcome for patients with myeloid disorders treated with fludarabine–melphalan reduced‐intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T‐lymphocyte‐depleting antibodies

Ram Malladi, Andy Peniket, Alice Norton,

European Journal Of Haematology

2004

13

Update on the clinical use and misuse of erythropoietin.

Helen Eagleton, Timothy J. Littlewood

PubMed

2003

13

Page 1